Stada Grows Twice As Fast As CHC Market In 2023

Stada's local brand focus helped it deliver Consumer Healthcare sales growth of 16% in 2023 ensuring the German firm significantly outpaced the overall market growth rate of 7%.

Stada_HQ
• Source: Stada

Stada’s Consumer Healthcare business grew more than twice as fast as the global OTC market in 2023 as sales increased across all regions.

The Bad Vilbel, Germany-based firm reported CHC sales up 16% to €1.49bn ($1.62bn) over the 12 months, outpacing a non-prescription...

More from Earnings

More from Business

AESGP Annual Meeting: European OTC Market Outlook ‘Very Positive’ Thanks To Prevention Trend

 
• By 

The European OTC market grew at double the rate of the global market in the last twelve months, according to IQVIA Consumer Health, driven by a long-term trend for prevention. Consultancy Simon Kucher identifies a desire to live a longer, healthier life as the primary concern behind this trend.

Poland’s Formeds Acquired By Private Equity

 
• By 

Enterprise Investors takes 77% stake in Polish clean-label dietary supplements manufacturer Formeds.

BioGaia Takes Probiotics To Netherlands For First Time

 
• By 

Adopting an online approach, BioGaia is set to enter the Dutch market for probiotic dietary supplements. The firm announced the move as it reported lower sales in Q1.